Technical Analysis for MTNB - Matinas Biopharma Holdings, Inc.

Grade Last Price % Change Price Change
grade C 0.99 5.32% 0.05
MTNB closed up 5.32 percent on Friday, May 17, 2019, on 3.67 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical MTNB trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Stochastic Buy Signal Bullish 5.32%
180 Bearish Setup Bearish Swing Setup 8.11%
Stochastic Reached Oversold Weakness 8.11%
Earnings Movers Other 8.11%
Oversold Stochastic Weakness 8.11%
Lower Bollinger Band Walk Weakness 4.40%
Earnings Movers Other 4.40%

Older signals for MTNB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections. Its cochleate delivery technology platform is designed for the targeted delivery of pharmaceuticals directly to the site of infection or inflammation. Its MAT 2203 is an oral formulation of a spectrum anti-fungal drug called amphotericin B, which uses its cochleate delivery technology. Its MAT2501 is an orally administered, encochleated formulation of the spectrum aminoglycoside antibiotic amikacin, which may be used to treat different types of multidrug-resistant bacteria, including non-tubercular mycobacterial infections (NTM), as well as various multidrug-resistant gram negative and intracellular bacterial infections.
Medicine Biopharmaceutical Medical Specialties Pharmaceuticals Drugs Inflammation Infection Antibiotic Antimicrobial Resistance Multiple Drug Resistance Amphotericin B Drug Resistance Serious And Life Threatening Infections
Is MTNB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.5
52 Week Low 0.32
Average Volume 1,033,989
200-Day Moving Average 0.8441
50-Day Moving Average 1.0829
20-Day Moving Average 1.0007
10-Day Moving Average 0.9804
Average True Range 0.0796
ADX 19.29
+DI 17.5719
-DI 20.9263
Chandelier Exit (Long, 3 ATRs ) 0.8812
Chandelier Exit (Short, 3 ATRs ) 1.1088
Upper Bollinger Band 1.0999
Lower Bollinger Band 0.9015
Percent B (%b) 0.45
BandWidth 19.826122
MACD Line -0.0334
MACD Signal Line -0.0307
MACD Histogram -0.0027
Fundamentals Value
Market Cap 91.05 Million
Num Shares 92 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -2.15
Price-to-Sales 1705.03
Price-to-Book 10.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.09
Resistance 3 (R3) 1.09 1.06 1.07
Resistance 2 (R2) 1.06 1.04 1.06 1.06
Resistance 1 (R1) 1.03 1.03 1.01 1.02 1.06
Pivot Point 1.00 1.00 0.99 1.00 1.00
Support 1 (S1) 0.96 0.98 0.95 0.96 0.92
Support 2 (S2) 0.94 0.96 0.93 0.92
Support 3 (S3) 0.90 0.94 0.91
Support 4 (S4) 0.89